Research on persistent and ongoing cancer trends can improve current treatment and care for cancer patients. Global Burden of Disease Cancer Collaboration (2017) argues that lung and breast cancer are the top two types of cancer for disability-adjusted life years (DALYs). Lortet-Tieulent et al. (2016) note colorectal one is the third on this list. Non-Hispanic Black and white people are the most vulnerable populations, while Hispanic and non-Hispanic Asian people are the groups with the lowest DALY rates (Lortet-Tieulent et al., 2016). This data enables healthcare managers to provide more fair service provision and allocate material, human, and other resources more efficiently.
Lung Cancer in Non-Hispanic Asians
As noted above, non-Hispanic Asians have the lowest lung cancer DALYs. According to Lortet-Tieulent et al. (2016), “non-Hispanic Asians exhibited lower ASR for “all cancers” and common cancers” (p. 673). This fact leads to two conflicting conclusions; the first is that this population receives adequate health services and resources. The second one is that this group does not have sufficient funds or access to screening and detection services.
Prostate, Liver, and Stomach Cancer
When analyzing persistent and current cancer trends, one should not limit the scope of their research to top trends only. Men of African descent suffer the most from prostate cancer in the United States (Rebbeck, 2017). The experts also note that “American Indians / Alaska Natives have the highest rates of liver and intrahepatic bile duct cancer” (Cancer disparities, 2020, para. 6). These facts provide a prerequisite for revising and adjusting the strategy for distributing health services for populations facing health barriers and living in remote areas. Stomach cancer has contributed about 11.5 million DALYs as of 2015 (Global Burden of Disease Cancer Collaboration, 2017). It means that these patients with this condition receive inadequate treatment, and this disease is poorly detected and prevented.
References
Cancer disparities. (2020). National Cancer Institute. Web.
Global Burden of Disease Cancer Collaboration. (2017). Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncology, 3(4), 524-548. Web.
Lortet-Tieulent, J., Soerjomataram, I., Lin, C. C., Coebergh, J. W. W., & Jemal, A. (2016). U.S. burden of cancer by race and ethnicity according to disability-adjusted life years. American Journal of Preventive Medicine, 51(5), 673-681. Web.
Rebbeck, T. R. (2017). Prostate cancer genetics: Variation by race, ethnicity, and geography. Seminars in Radiation Oncology, 27(1), 3-10. Web.